Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nitric oxide - Thirty Respiratory

Next Previous
Search
Drug Profile

Nitric oxide - Thirty Respiratory

Alternative Names: RESP-301

Latest Information Update: 25 Dec 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Thirty respiratory
  • Class Anti-infectives; Anti-inflammatories; Antiacnes; Antiandrogens; Antibacterials; Antibronchitics; Antifibrotics; Antifungals; Antihypertensives; Antineoplastics; Antituberculars; Antivirals; Cardiovascular therapies; Diagnostic agents; Foot disorder therapies; Free radicals; Nitrogen oxides; Non-opioid analgesics; Skin disorder therapies; Small molecules; Vascular disorder therapies; Vasodilators
  • Mechanism of Action Membrane fusion protein inhibitors; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Tuberculosis
  • No development reported Respiratory tract infections

Most Recent Events

  • 18 Dec 2023 Thirty Respiratory terminates a phase II/III trial in COVID 2019 infetcion in the UK due to dynamic nature of the COVID-19 pandemic and a very sharp decline in the COVID-19 patients post vaccination (NCT04842331)
  • 12 Dec 2023 Thirty Respiratory completes a phase-II clinical trials in Tuberculosis in United Kingdom (Inhalation) (ISRTCN14833199)
  • 27 Sep 2023 Phase-II clinical trials in Tuberculosis (Treatment-naive) in South Africa (Inhalation) (NCT06041919)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top